Medpace Holdings (MEDP) Net Shares Issued and Repurchased (2015 - 2022)

Medpace Holdings (MEDP) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $240243.0 the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Net Shares Issued and Repurchased rose 1902.02% year-over-year to $240243.0; the trailing twelve-month figure through Mar 2022 stood at $240243.0 (up 1902.02% YoY), and the FY2021 full-year result was $282588.0, up 24.29% from the prior year.
• Net Shares Issued and Repurchased retreated to $240243.0 in Q1 2022 per MEDP's latest filing, from $282588.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $859960.0 in Q4 2019 and bottomed at $12000.0 in Q1 2021.
• Historically, Net Shares Issued and Repurchased has averaged $324085.2 across 5 years, with a median of $240243.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased sank 93.98% in 2021, then soared 1902.02% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $584301.0 in 2018, then soared by 47.18% to $859960.0 in 2019, then slumped by 73.56% to $227353.0 in 2020, then gained by 24.29% to $282588.0 in 2021, then retreated by 14.98% to $240243.0 in 2022.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $240243.0, $282588.0, and $12000.0 for Q1 2022, Q4 2021, and Q1 2021 respectively.